These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38262901)

  • 21. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
    Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
    Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kuwata T; Tokunaga M; Kaito A; Watanabe M; Tonouchi A; Sato R; Nagino M
    Surg Endosc; 2021 Jan; 35(1):340-348. PubMed ID: 32025923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of survival and prognosis of Siewert Ⅱ/Ⅲ esophagogastric junction adenocarcinoma patients with non-operative acute upper gastrointestinal hemorrhage].
    Tian L; Yu L
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1881-1885. PubMed ID: 32575932
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
    Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
    Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of a novel nomogram for predicting overall survival in patients with Siewert type II AEG based on LODDS: a study based on the seer database and external validation.
    Yu X; Bai C; Yu Y; Guo X; Wang K; Yang H; Luan X
    Front Oncol; 2024; 14():1396339. PubMed ID: 38912066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography-based nomogram of Siewert type II/III adenocarcinoma of esophagogastric junction to predict response to docetaxel, oxaliplatin and S-1.
    Zhou CQ; Gao D; Gui Y; Li NP; Guo WW; Zhou HY; Li R; Chen J; Zhang XM; Chen TW
    World J Radiol; 2024 Jan; 16(1):9-19. PubMed ID: 38312347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective cohort study (the AMONP corhort).
    Zhang JW; Huang L; Xu AM
    Oncotarget; 2017 Aug; 8(34):57516-57527. PubMed ID: 28915691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.
    Lin X; Li Z; Tan C; Ye X; Xiong J; Liu J; Mo A; Shi Y; Qian F; Yu P; Zhao Y
    Front Oncol; 2021; 11():748694. PubMed ID: 34926257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score.
    Galizia G; Auricchio A; de Vita F; Cardella F; Mabilia A; Basile N; Orditura M; Lieto E
    Ann Ital Chir; 2019; 90():404-416. PubMed ID: 31814602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of laparoscopic gastrectomy for patients with Siewert-type II/III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis.
    Shi Y; Li L; Xiao H; Guo S; Wang G; Tao K; Dong J; Zong L
    PLoS One; 2018; 13(9):e0203125. PubMed ID: 30256806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multicenter, Observational Study.
    Nie RC; Luo TQ; Li GD; Zhang FY; Chen GM; Li JX; Chen XJ; Zhao ZK; Jiang KM; Wei YC; Huang MW; Chen S; Chen YB
    Ann Surg Oncol; 2023 Jul; 30(7):4014-4025. PubMed ID: 36566257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of efficacy between laparoscopic and open proximal gastrectomy with double-tract reconstruction for Siewert type Ⅱ and Ⅲ adenocarcinoma of the esophagogastric junction].
    Ma F; Peng LQ; Liu CP; Zhang YL; Wang L; Zhang B; Ma Q; Ji SQ; Chai JH; Tang XC; Zhao EJ; Hua YW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):420-425. PubMed ID: 34000771
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of lymph node (No.5 and No.6) metastasis and significance of lymph node dissection in Siewert type II esophagogastric junction adenocarcinoma (AEG): No.5 and No.6 lymph node metastases of AEG and clearance.
    Zhang X; He XD; Zhang YC; Yang KH; Tian JH; Chen YL
    Medicine (Baltimore); 2021 Sep; 100(35):e27106. PubMed ID: 34477150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study.
    Du R; Ming J; Geng J; Zhu X; Zhang Y; Li S; Liu Z; Wang H; Wang Z; Tang L; Zhang X; Wu A; Bu Z; Yan Y; Li Z; Li Y; Li Z; Wang W
    Radiat Oncol; 2022 Mar; 17(1):45. PubMed ID: 35241109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of preoperative immune-nutritional scoring systems in remnant gastric cancer patients undergoing surgery.
    Zhang Y; Wang LJ; Li QY; Yuan Z; Zhang DC; Xu H; Yang L; Gu XH; Xu ZK
    World J Gastrointest Surg; 2023 Feb; 15(2):211-221. PubMed ID: 36896300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery.
    Zheng C; Feng X; Zheng J; Yan Q; Hu X; Feng H; Deng Z; Liao Q; Wang J; Li Y
    Cancer Manag Res; 2020; 12():12791-12799. PubMed ID: 33364828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
    Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.